These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 23815913)
1. [Relation of B7-H3 molecule expression in multiple myeloma with poor prognosis and bone destruction]. Zhao DD; Lin L; Ge Q; Li ZY; He XP; Xu KL; Lu J; Huang XJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):637-42. PubMed ID: 23815913 [TBL] [Abstract][Full Text] [Related]
2. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3. Lin L; Cao L; Liu Y; Wang K; Zhang X; Qin X; Zhao D; Hao J; Chang Y; Huang X; Liu B; Zhang J; Lu J; Ge Q Leukemia; 2019 Jun; 33(6):1475-1486. PubMed ID: 30573782 [TBL] [Abstract][Full Text] [Related]
3. LncRNA NEAT1 sponges miR-214 to regulate M2 macrophage polarization by regulation of B7-H3 in multiple myeloma. Gao Y; Fang P; Li WJ; Zhang J; Wang GP; Jiang DF; Chen FP Mol Immunol; 2020 Jan; 117():20-28. PubMed ID: 31731055 [TBL] [Abstract][Full Text] [Related]
4. Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia. Hu Y; Lv X; Wu Y; Xu J; Wang L; Chen W; Zhang W; Li J; Zhang S; Qiu H Hematology; 2015 May; 20(4):187-95. PubMed ID: 25130683 [TBL] [Abstract][Full Text] [Related]
5. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer. Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202 [TBL] [Abstract][Full Text] [Related]
6. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer. Zhang P; Yu S; Li H; Liu C; Li J; Lin W; Gao A; Wang L; Gao W; Sun Y FEBS Lett; 2015 Aug; 589(17):2248-56. PubMed ID: 26149216 [TBL] [Abstract][Full Text] [Related]
7. Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer. Zhang T; Wang F; Wu JY; Qiu ZC; Wang Y; Liu F; Ge XS; Qi XW; Mao Y; Hua D World J Gastroenterol; 2018 Aug; 24(31):3538-3546. PubMed ID: 30131660 [TBL] [Abstract][Full Text] [Related]
8. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance. Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of costimulatory molecule B7-H3 expression on CD3(+) T cells in colorectal carcinoma. Mao Y; Sun J; Wang WP; Zhang XG; Hua D Chin Med J (Engl); 2013 Aug; 126(16):3035-8. PubMed ID: 23981607 [TBL] [Abstract][Full Text] [Related]
10. B7-H3 expression in ductal and lobular breast cancer and its association with IL-10. Liu C; Liu J; Wang J; Liu Y; Zhang F; Lin W; Gao A; Sun M; Wang Y; Sun Y Mol Med Rep; 2013 Jan; 7(1):134-8. PubMed ID: 23128494 [TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of soluble B7-H3 in sera of patients with primary hepatocellular carcinoma]. Wang F; Yu G; Liu T; Wang G; Yang J; Zhang G; Luan X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):629-32. PubMed ID: 23746248 [TBL] [Abstract][Full Text] [Related]
12. B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity. Zhang W; Wang Y; Wang J; Dong F; Zhu M; Wan W; Li H; Wu F; Yan X; Ke X Int J Oncol; 2015; 46(6):2562-72. PubMed ID: 25872657 [TBL] [Abstract][Full Text] [Related]
14. B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer. Ingebrigtsen VA; Boye K; Tekle C; Nesland JM; Flatmark K; Fodstad O Int J Cancer; 2012 Dec; 131(11):2528-36. PubMed ID: 22473715 [TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis. Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044 [TBL] [Abstract][Full Text] [Related]
16. A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients. Kuranda K; Berthon C; Dupont C; Wolowiec D; Leleu X; Polakowska R; Jouy N; Quesnel B Exp Hematol; 2010 Feb; 38(2):124-31. PubMed ID: 19948206 [TBL] [Abstract][Full Text] [Related]
17. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Arigami T; Uenosono Y; Hirata M; Yanagita S; Ishigami S; Natsugoe S Cancer Sci; 2011 May; 102(5):1019-24. PubMed ID: 21251161 [TBL] [Abstract][Full Text] [Related]
18. B7-H3 and its role in bone cancers. He L; Li Z Pathol Res Pract; 2019 Jun; 215(6):152420. PubMed ID: 31060912 [TBL] [Abstract][Full Text] [Related]
19. B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients. Pizon M; Schott DS; Pachmann U; Pachmann K Int J Oncol; 2018 Nov; 53(5):2289-2299. PubMed ID: 30226585 [TBL] [Abstract][Full Text] [Related]
20. [Expression of B7-H3 costimulatory molecule in peripheral blood of myasthenia gravis patients]. Jiang JA; Xue Q; Liu CP; Gao L; Zhang GB; Chen YJ; Zhang XG Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):856-9. PubMed ID: 22863596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]